Hims & Hers Health Raises FY24 Revenue Guidance From $1.20B - $1.23B To $1.37B - $1.40B, Est $1.244B
Portfolio Pulse from Benzinga Newsdesk
Hims & Hers Health has raised its FY24 revenue guidance from $1.20B - $1.23B to $1.37B - $1.40B, surpassing the estimated $1.244B. The company also increased its full-year 2024 Adjusted EBITDA guidance to a range of $140 million to $155 million.
August 05, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health has raised its FY24 revenue guidance to $1.37B - $1.40B, exceeding the estimated $1.244B. The company also increased its full-year 2024 Adjusted EBITDA guidance to $140 million to $155 million.
The raised revenue and Adjusted EBITDA guidance indicate strong financial performance and growth prospects for Hims & Hers Health. This positive outlook is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100